Qiagen's consumables kits have now been used to process more than 3 billion biological samples. Furthermore, the company's next-generation sequencing assays have been utilized to test 1 million samples since 2015.
Qiagen said that sample technology is one of its five pillars of growth, along with its Quantiferon immune-response technology, NeuMoDx integrated polymerase chain reaction (PCR) system, QIAstat-Dx syndromic testing system, and QIAcuity digital PCR portfolio.